ORKA
Oruka Therapeutics
ORKA
ORKA
20 hedge funds and large institutions have $2.41M invested in Oruka Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.24% less ownership
Funds ownership: 0.88% → 0.65% (-0.24%)
47% less capital invested
Capital invested by funds: $4.53M → $2.41M (-$2.12M)
Holders
20
Holding in Top 10
–
Calls
$169K
Puts
$147K
Top Buyers
| 1 | +$123K | |
| 2 | +$91K | |
| 3 | +$29.3K | |
| 4 |
Millennium Management
New York
|
+$27K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$23.6K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$168K | |
| 3 | -$49K | |
| 4 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
-$30K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23.6K |